"The Caotang Base of Xi'an High-tech Zone opens a 'convenient door' for enterprises to resume work and helps us get the approval letter for resumption of work and production as soon as possible. We will conscientiously implement the main responsibilities of the enterprise, ensure

"Xi'an High-tech Zone Caotang Base opens a 'convenient door' for enterprises to resume work and helps us get the approval letter for resumption of work and production as soon as possible. We will conscientiously implement the main responsibilities of the enterprise and ensure that epidemic prevention and control measures are in place and resolutely adhere to them. 'Safety door'. At present, the company's production capacity has been restored to about 65%, and it is expected to achieve quarterly growth." On the afternoon of February 18, the relevant person in charge of Xi'an Janssen Pharmaceutical said to the staff of the Caotang base who were conducting routine visits and inspections.

Xi'an Janssen is a large multinational pharmaceutical manufacturer whose products are sold in the Asia-Pacific region and domestically. On February 5, Xi'an Janssen applied to the Caotang base for resumption of work and production. After receiving the application, Caotang Base immediately set up a special class to take the initiative to provide door-to-door docking, door-to-door acceptance, door-to-door approval, and door-to-door service. It provided full-process and all-round guidance for enterprises to resume work and production, and strictly and quickly carried out "pre-examination by dedicated personnel, group discussions, and special class review "In the three-phase work, the dedicated work team worked continuously for 20 hours. The approval was successfully completed in the early morning of February 6, and production was resumed on the same day. Since the date of resumption of work, dedicated staff will visit the company every day to visit the company's needs, supervise the company's implementation of epidemic prevention measures, and help the company coordinate and solve problems such as employee residence access and raw material transportation. Currently, the company's two pharmaceutical production lines and one packaging line are operating at high speed, and the production capacity has been restored to about 65%. The output value in the first quarter of 2020 is expected to exceed 2.4 billion. Compared with the output value of 2.3 billion in the first quarter of 2019, it will achieve quarterly year-on-year growth.

On the premise of ensuring that epidemic prevention materials, management and control, personnel and safety are in place, Xi'an High-tech Zone Caotang Base will accept applications as soon as possible: no avoidance, no shirk; first time visit: no delay, no fear of tiredness; first time acceptance Approval: If the standards are not met, no release; First-time acceptance: Don’t let it go, don’t miss it; First-time coordination: Don’t solve or give up based on the “five first times” and “ten no” principles, and strive to improve the company The efficiency of approval for resumption of work and production, and dedicated personnel stationed in the company to provide services, help companies resume production and restore production capacity as soon as possible. Up to now, 22 enterprises in the Caotang Base involving the production of epidemic prevention materials, people's livelihood security and key industries have resumed work, with nearly 7,000 people returning to work. The entire park is full of vitality.

(correspondent Lu Hongwei)